nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Topotecan—peripheral nervous system neoplasm	0.229	0.531	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Epirubicin—peripheral nervous system neoplasm	0.105	0.244	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Doxorubicin—peripheral nervous system neoplasm	0.0972	0.226	CiPCiCtD
Etoposide—brain cancer—peripheral nervous system neoplasm	0.0923	0.355	CtDrD
Etoposide—muscle cancer—peripheral nervous system neoplasm	0.0622	0.239	CtDrD
Etoposide—germ cell cancer—peripheral nervous system neoplasm	0.0559	0.215	CtDrD
Etoposide—ABCB1—peripheral nervous system neoplasm	0.05	1	CbGaD
Etoposide—sarcoma—peripheral nervous system neoplasm	0.0496	0.191	CtDrD
Etoposide—GSTT1—Cisplatin—peripheral nervous system neoplasm	0.0222	0.111	CbGbCtD
Etoposide—ABCC6—Dactinomycin—peripheral nervous system neoplasm	0.0222	0.111	CbGbCtD
Etoposide—GSTP1—Cisplatin—peripheral nervous system neoplasm	0.0138	0.0691	CbGbCtD
Etoposide—ABCC6—Cisplatin—peripheral nervous system neoplasm	0.0127	0.0635	CbGbCtD
Etoposide—ABCC10—Vincristine—peripheral nervous system neoplasm	0.0104	0.052	CbGbCtD
Etoposide—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.00854	0.0426	CbGbCtD
Etoposide—ABCC6—Doxorubicin—peripheral nervous system neoplasm	0.00853	0.0426	CbGbCtD
Etoposide—ABCC3—Vincristine—peripheral nervous system neoplasm	0.00656	0.0327	CbGbCtD
Etoposide—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.00654	0.0326	CbGbCtD
Etoposide—ABCC10—Doxorubicin—peripheral nervous system neoplasm	0.00652	0.0325	CbGbCtD
Etoposide—ABCG2—Topotecan—peripheral nervous system neoplasm	0.00631	0.0315	CbGbCtD
Etoposide—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.00611	0.0305	CbGbCtD
Etoposide—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.00473	0.0236	CbGbCtD
Etoposide—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.00454	0.0227	CbGbCtD
Etoposide—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.00437	0.0218	CbGbCtD
Etoposide—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.0041	0.0205	CbGbCtD
Etoposide—ABCC1—Vincristine—peripheral nervous system neoplasm	0.00403	0.0201	CbGbCtD
Etoposide—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0036	0.018	CbGbCtD
Etoposide—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.00325	0.0162	CbGbCtD
Etoposide—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.00313	0.0156	CbGbCtD
Etoposide—ABCC2—Vincristine—peripheral nervous system neoplasm	0.00298	0.0149	CbGbCtD
Etoposide—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.00278	0.0139	CbGbCtD
Etoposide—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.00275	0.0137	CbGbCtD
Etoposide—ABCG2—Vincristine—peripheral nervous system neoplasm	0.00269	0.0134	CbGbCtD
Etoposide—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0026	0.013	CbGbCtD
Etoposide—ABCC1—Doxorubicin—peripheral nervous system neoplasm	0.00252	0.0126	CbGbCtD
Etoposide—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.00251	0.0125	CbGbCtD
Etoposide—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00228	0.0114	CbGbCtD
Etoposide—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00228	0.0114	CbGbCtD
Etoposide—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.00208	0.0104	CbGbCtD
Etoposide—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.00186	0.0093	CbGbCtD
Etoposide—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00168	0.00841	CbGbCtD
Etoposide—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00158	0.00787	CbGbCtD
Etoposide—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.00149	0.00745	CbGbCtD
Etoposide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00136	0.00681	CbGbCtD
Etoposide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00127	0.00633	CbGbCtD
Etoposide—ABCB1—Vincristine—peripheral nervous system neoplasm	0.000971	0.00485	CbGbCtD
Etoposide—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.000906	0.00452	CbGbCtD
Etoposide—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.000607	0.00303	CbGbCtD
Etoposide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.000582	0.00291	CbGbCtD
Etoposide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.00182	CbGbCtD
Etoposide—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000229	0.298	CbGdCrCtD
Etoposide—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	0.000136	0.177	CbGdCrCtD
Etoposide—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	8.59e-05	0.112	CbGdCrCtD
Etoposide—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	5.9e-05	0.0768	CbGdCrCtD
Etoposide—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.0582	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.0582	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.0582	CbGdCrCtD
Etoposide—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.0539	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.0539	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	4.14e-05	0.0539	CbGdCrCtD
Etoposide—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	2.75e-05	0.000529	CcSEcCtD
Etoposide—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	2.73e-05	0.000525	CcSEcCtD
Etoposide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	2.73e-05	0.000525	CcSEcCtD
Etoposide—Somnolence—Alitretinoin—peripheral nervous system neoplasm	2.72e-05	0.000523	CcSEcCtD
Etoposide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	2.72e-05	0.000523	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	2.7e-05	0.00052	CcSEcCtD
Etoposide—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	2.7e-05	0.000519	CcSEcCtD
Etoposide—Dizziness—Topotecan—peripheral nervous system neoplasm	2.69e-05	0.000518	CcSEcCtD
Etoposide—Discomfort—Cisplatin—peripheral nervous system neoplasm	2.69e-05	0.000517	CcSEcCtD
Etoposide—Dizziness—Tretinoin—peripheral nervous system neoplasm	2.67e-05	0.000514	CcSEcCtD
Etoposide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	2.67e-05	0.000514	CcSEcCtD
Etoposide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	2.66e-05	0.000512	CcSEcCtD
Etoposide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	2.65e-05	0.000509	CcSEcCtD
Etoposide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	2.64e-05	0.000508	CcSEcCtD
Etoposide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	2.64e-05	0.000508	CcSEcCtD
Etoposide—Constipation—Alitretinoin—peripheral nervous system neoplasm	2.62e-05	0.000503	CcSEcCtD
Etoposide—Pain—Alitretinoin—peripheral nervous system neoplasm	2.62e-05	0.000503	CcSEcCtD
Etoposide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	2.61e-05	0.000502	CcSEcCtD
Etoposide—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	2.61e-05	0.000502	CcSEcCtD
Etoposide—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	2.61e-05	0.000502	CcSEcCtD
Etoposide—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000501	CcSEcCtD
Etoposide—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	2.59e-05	0.000498	CcSEcCtD
Etoposide—Infection—Cisplatin—peripheral nervous system neoplasm	2.59e-05	0.000498	CcSEcCtD
Etoposide—Vomiting—Topotecan—peripheral nervous system neoplasm	2.59e-05	0.000498	CcSEcCtD
Etoposide—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	2.58e-05	0.000497	CcSEcCtD
Etoposide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	2.57e-05	0.000494	CcSEcCtD
Etoposide—Vomiting—Tretinoin—peripheral nervous system neoplasm	2.57e-05	0.000494	CcSEcCtD
Etoposide—Rash—Topotecan—peripheral nervous system neoplasm	2.57e-05	0.000494	CcSEcCtD
Etoposide—Dermatitis—Topotecan—peripheral nervous system neoplasm	2.56e-05	0.000493	CcSEcCtD
Etoposide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	2.56e-05	0.000493	CcSEcCtD
Etoposide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	2.55e-05	0.000491	CcSEcCtD
Etoposide—Headache—Topotecan—peripheral nervous system neoplasm	2.55e-05	0.000491	CcSEcCtD
Etoposide—Rash—Tretinoin—peripheral nervous system neoplasm	2.55e-05	0.00049	CcSEcCtD
Etoposide—Rash—Isotretinoin—peripheral nervous system neoplasm	2.55e-05	0.00049	CcSEcCtD
Etoposide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	2.55e-05	0.00049	CcSEcCtD
Etoposide—Tachycardia—Cisplatin—peripheral nervous system neoplasm	2.55e-05	0.00049	CcSEcCtD
Etoposide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	2.54e-05	0.000489	CcSEcCtD
Etoposide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	2.54e-05	0.000489	CcSEcCtD
Etoposide—Fatigue—Vincristine—peripheral nervous system neoplasm	2.54e-05	0.000489	CcSEcCtD
Etoposide—Vomiting—Melphalan—peripheral nervous system neoplasm	2.53e-05	0.000488	CcSEcCtD
Etoposide—Skin disorder—Cisplatin—peripheral nervous system neoplasm	2.53e-05	0.000487	CcSEcCtD
Etoposide—Headache—Tretinoin—peripheral nervous system neoplasm	2.53e-05	0.000487	CcSEcCtD
Etoposide—Headache—Isotretinoin—peripheral nervous system neoplasm	2.53e-05	0.000487	CcSEcCtD
Etoposide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	2.52e-05	0.000485	CcSEcCtD
Etoposide—Constipation—Vincristine—peripheral nervous system neoplasm	2.52e-05	0.000485	CcSEcCtD
Etoposide—Pain—Vincristine—peripheral nervous system neoplasm	2.52e-05	0.000485	CcSEcCtD
Etoposide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	2.52e-05	0.000485	CcSEcCtD
Etoposide—Rash—Melphalan—peripheral nervous system neoplasm	2.51e-05	0.000483	CcSEcCtD
Etoposide—Dermatitis—Melphalan—peripheral nervous system neoplasm	2.51e-05	0.000483	CcSEcCtD
Etoposide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	2.5e-05	0.000481	CcSEcCtD
Etoposide—Anorexia—Cisplatin—peripheral nervous system neoplasm	2.49e-05	0.000478	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	2.45e-05	0.000472	CcSEcCtD
Etoposide—Hypotension—Cisplatin—peripheral nervous system neoplasm	2.44e-05	0.000469	CcSEcCtD
Etoposide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	2.43e-05	0.000468	CcSEcCtD
Etoposide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	2.43e-05	0.000468	CcSEcCtD
Etoposide—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	2.42e-05	0.000465	CcSEcCtD
Etoposide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	2.42e-05	0.000465	CcSEcCtD
Etoposide—Nausea—Topotecan—peripheral nervous system neoplasm	2.42e-05	0.000465	CcSEcCtD
Etoposide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	2.41e-05	0.000464	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	2.4e-05	0.000462	CcSEcCtD
Etoposide—Nausea—Tretinoin—peripheral nervous system neoplasm	2.4e-05	0.000461	CcSEcCtD
Etoposide—Nausea—Isotretinoin—peripheral nervous system neoplasm	2.4e-05	0.000461	CcSEcCtD
Etoposide—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000461	CcSEcCtD
Etoposide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	2.37e-05	0.000456	CcSEcCtD
Etoposide—Nausea—Melphalan—peripheral nervous system neoplasm	2.37e-05	0.000455	CcSEcCtD
Etoposide—Dysphagia—Epirubicin—peripheral nervous system neoplasm	2.36e-05	0.000453	CcSEcCtD
Etoposide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	2.34e-05	0.00045	CcSEcCtD
Etoposide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	2.33e-05	0.000448	CcSEcCtD
Etoposide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	2.33e-05	0.000448	CcSEcCtD
Etoposide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	2.33e-05	0.000447	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	2.27e-05	0.000437	CcSEcCtD
Etoposide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	2.27e-05	0.000436	CcSEcCtD
Etoposide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	2.26e-05	0.000434	CcSEcCtD
Etoposide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	2.26e-05	0.000434	CcSEcCtD
Etoposide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	2.25e-05	0.000433	CcSEcCtD
Etoposide—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	2.24e-05	0.00043	CcSEcCtD
Etoposide—Pain—Cisplatin—peripheral nervous system neoplasm	2.23e-05	0.000429	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	2.22e-05	0.000428	CcSEcCtD
Etoposide—Neutropenia—Epirubicin—peripheral nervous system neoplasm	2.2e-05	0.000424	CcSEcCtD
Etoposide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	2.2e-05	0.000422	CcSEcCtD
Etoposide—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	2.18e-05	0.000419	CcSEcCtD
Etoposide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	2.17e-05	0.000418	CcSEcCtD
Etoposide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	2.17e-05	0.000417	CcSEcCtD
Etoposide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	2.15e-05	0.000413	CcSEcCtD
Etoposide—Asthenia—Vincristine—peripheral nervous system neoplasm	2.12e-05	0.000407	CcSEcCtD
Etoposide—Pneumonia—Epirubicin—peripheral nervous system neoplasm	2.11e-05	0.000406	CcSEcCtD
Etoposide—Infestation—Epirubicin—peripheral nervous system neoplasm	2.1e-05	0.000404	CcSEcCtD
Etoposide—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	2.1e-05	0.000404	CcSEcCtD
Etoposide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	2.1e-05	0.000404	CcSEcCtD
Etoposide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	2.09e-05	0.000403	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	2.08e-05	0.0004	CcSEcCtD
Etoposide—Rash—Dactinomycin—peripheral nervous system neoplasm	2.08e-05	0.0004	CcSEcCtD
Etoposide—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	2.07e-05	0.000398	CcSEcCtD
Etoposide—Renal failure—Epirubicin—peripheral nervous system neoplasm	2.06e-05	0.000397	CcSEcCtD
Etoposide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	2.06e-05	0.000397	CcSEcCtD
Etoposide—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	2.06e-05	0.000396	CcSEcCtD
Etoposide—Jaundice—Epirubicin—peripheral nervous system neoplasm	2.05e-05	0.000394	CcSEcCtD
Etoposide—Stomatitis—Epirubicin—peripheral nervous system neoplasm	2.05e-05	0.000394	CcSEcCtD
Etoposide—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	2.04e-05	0.000392	CcSEcCtD
Etoposide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	2.02e-05	0.000389	CcSEcCtD
Etoposide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	2.02e-05	0.000388	CcSEcCtD
Etoposide—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	1.99e-05	0.000382	CcSEcCtD
Etoposide—Nausea—Dactinomycin—peripheral nervous system neoplasm	1.96e-05	0.000377	CcSEcCtD
Etoposide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	1.96e-05	0.000377	CcSEcCtD
Etoposide—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	1.95e-05	0.000376	CcSEcCtD
Etoposide—Dizziness—Vincristine—peripheral nervous system neoplasm	1.95e-05	0.000375	CcSEcCtD
Etoposide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	1.95e-05	0.000374	CcSEcCtD
Etoposide—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	1.94e-05	0.000374	CcSEcCtD
Etoposide—Infestation—Doxorubicin—peripheral nervous system neoplasm	1.94e-05	0.000374	CcSEcCtD
Etoposide—Rash—Alitretinoin—peripheral nervous system neoplasm	1.93e-05	0.000371	CcSEcCtD
Etoposide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	1.93e-05	0.000371	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	1.93e-05	0.00037	CcSEcCtD
Etoposide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	1.92e-05	0.00037	CcSEcCtD
Etoposide—Headache—Alitretinoin—peripheral nervous system neoplasm	1.92e-05	0.000369	CcSEcCtD
Etoposide—Renal failure—Doxorubicin—peripheral nervous system neoplasm	1.91e-05	0.000367	CcSEcCtD
Etoposide—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	1.9e-05	0.000366	CcSEcCtD
Etoposide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	0.000364	CcSEcCtD
Etoposide—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	1.89e-05	0.000364	CcSEcCtD
Etoposide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	1.88e-05	0.000361	CcSEcCtD
Etoposide—Vomiting—Vincristine—peripheral nervous system neoplasm	1.88e-05	0.000361	CcSEcCtD
Etoposide—Asthenia—Cisplatin—peripheral nervous system neoplasm	1.87e-05	0.00036	CcSEcCtD
Etoposide—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	1.86e-05	0.000358	CcSEcCtD
Etoposide—Rash—Vincristine—peripheral nervous system neoplasm	1.86e-05	0.000358	CcSEcCtD
Etoposide—Dermatitis—Vincristine—peripheral nervous system neoplasm	1.86e-05	0.000357	CcSEcCtD
Etoposide—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	1.85e-05	0.000355	CcSEcCtD
Etoposide—Headache—Vincristine—peripheral nervous system neoplasm	1.85e-05	0.000355	CcSEcCtD
Etoposide—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	1.84e-05	0.000353	CcSEcCtD
Etoposide—Nausea—Alitretinoin—peripheral nervous system neoplasm	1.82e-05	0.00035	CcSEcCtD
Etoposide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	1.81e-05	0.000349	CcSEcCtD
Etoposide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	1.78e-05	0.000343	CcSEcCtD
Etoposide—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	1.78e-05	0.000343	CcSEcCtD
Etoposide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	1.76e-05	0.000339	CcSEcCtD
Etoposide—Nausea—Vincristine—peripheral nervous system neoplasm	1.75e-05	0.000337	CcSEcCtD
Etoposide—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	1.75e-05	0.000336	CcSEcCtD
Etoposide—Flushing—Epirubicin—peripheral nervous system neoplasm	1.75e-05	0.000336	CcSEcCtD
Etoposide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	1.74e-05	0.000334	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	1.72e-05	0.000331	CcSEcCtD
Etoposide—Angiopathy—Epirubicin—peripheral nervous system neoplasm	1.71e-05	0.000329	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	1.71e-05	0.000329	CcSEcCtD
Etoposide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	1.7e-05	0.000327	CcSEcCtD
Etoposide—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	1.7e-05	0.000327	CcSEcCtD
Etoposide—Chills—Epirubicin—peripheral nervous system neoplasm	1.69e-05	0.000325	CcSEcCtD
Etoposide—Alopecia—Epirubicin—peripheral nervous system neoplasm	1.67e-05	0.00032	CcSEcCtD
Etoposide—Vomiting—Cisplatin—peripheral nervous system neoplasm	1.66e-05	0.000319	CcSEcCtD
Etoposide—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	1.65e-05	0.000317	CcSEcCtD
Etoposide—Rash—Cisplatin—peripheral nervous system neoplasm	1.64e-05	0.000316	CcSEcCtD
Etoposide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	1.64e-05	0.000316	CcSEcCtD
Etoposide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	1.63e-05	0.000314	CcSEcCtD
Etoposide—Flushing—Doxorubicin—peripheral nervous system neoplasm	1.62e-05	0.000311	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	1.62e-05	0.000311	CcSEcCtD
Etoposide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	1.61e-05	0.000309	CcSEcCtD
Etoposide—Back pain—Epirubicin—peripheral nervous system neoplasm	1.59e-05	0.000305	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	1.58e-05	0.000304	CcSEcCtD
Etoposide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	1.58e-05	0.000303	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	1.58e-05	0.000303	CcSEcCtD
Etoposide—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	1.57e-05	0.000302	CcSEcCtD
Etoposide—Chills—Doxorubicin—peripheral nervous system neoplasm	1.57e-05	0.000301	CcSEcCtD
Etoposide—Nausea—Cisplatin—peripheral nervous system neoplasm	1.55e-05	0.000298	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	1.54e-05	0.000296	CcSEcCtD
Etoposide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	1.52e-05	0.000293	CcSEcCtD
Etoposide—Anaemia—Epirubicin—peripheral nervous system neoplasm	1.52e-05	0.000292	CcSEcCtD
Etoposide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	1.49e-05	0.000286	CcSEcCtD
Etoposide—Malaise—Epirubicin—peripheral nervous system neoplasm	1.48e-05	0.000285	CcSEcCtD
Etoposide—Vertigo—Epirubicin—peripheral nervous system neoplasm	1.47e-05	0.000284	CcSEcCtD
Etoposide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	1.47e-05	0.000283	CcSEcCtD
Etoposide—Back pain—Doxorubicin—peripheral nervous system neoplasm	1.47e-05	0.000282	CcSEcCtD
Etoposide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	1.46e-05	0.000281	CcSEcCtD
Etoposide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	1.44e-05	0.000277	CcSEcCtD
Etoposide—Cough—Epirubicin—peripheral nervous system neoplasm	1.43e-05	0.000275	CcSEcCtD
Etoposide—Convulsion—Epirubicin—peripheral nervous system neoplasm	1.42e-05	0.000273	CcSEcCtD
Etoposide—Hypertension—Epirubicin—peripheral nervous system neoplasm	1.42e-05	0.000272	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	1.41e-05	0.000271	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	1.4e-05	0.00027	CcSEcCtD
Etoposide—Chest pain—Epirubicin—peripheral nervous system neoplasm	1.4e-05	0.000269	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	1.39e-05	0.000267	CcSEcCtD
Etoposide—Discomfort—Epirubicin—peripheral nervous system neoplasm	1.38e-05	0.000265	CcSEcCtD
Etoposide—Malaise—Doxorubicin—peripheral nervous system neoplasm	1.37e-05	0.000263	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	1.36e-05	0.000262	CcSEcCtD
Etoposide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	1.36e-05	0.000261	CcSEcCtD
Etoposide—Confusional state—Epirubicin—peripheral nervous system neoplasm	1.35e-05	0.00026	CcSEcCtD
Etoposide—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	1.34e-05	0.000258	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	1.33e-05	0.000257	CcSEcCtD
Etoposide—Infection—Epirubicin—peripheral nervous system neoplasm	1.33e-05	0.000256	CcSEcCtD
Etoposide—Cough—Doxorubicin—peripheral nervous system neoplasm	1.33e-05	0.000255	CcSEcCtD
Etoposide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	1.32e-05	0.000253	CcSEcCtD
Etoposide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	1.31e-05	0.000252	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	1.31e-05	0.000252	CcSEcCtD
Etoposide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	1.31e-05	0.000251	CcSEcCtD
Etoposide—Skin disorder—Epirubicin—peripheral nervous system neoplasm	1.3e-05	0.00025	CcSEcCtD
Etoposide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	1.29e-05	0.000249	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	1.29e-05	0.000249	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	1.28e-05	0.000247	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	1.28e-05	0.000246	CcSEcCtD
Etoposide—Anorexia—Epirubicin—peripheral nervous system neoplasm	1.28e-05	0.000246	CcSEcCtD
Etoposide—Hypotension—Epirubicin—peripheral nervous system neoplasm	1.25e-05	0.000241	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	1.25e-05	0.00024	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	1.24e-05	0.000238	CcSEcCtD
Etoposide—Infection—Doxorubicin—peripheral nervous system neoplasm	1.23e-05	0.000237	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	1.21e-05	0.000233	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	1.21e-05	0.000233	CcSEcCtD
Etoposide—GSTP1—Metabolism—COX2—peripheral nervous system neoplasm	1.21e-05	0.00206	CbGpPWpGaD
Etoposide—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	1.2e-05	0.000232	CcSEcCtD
Etoposide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	1.2e-05	0.000231	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	1.2e-05	0.00023	CcSEcCtD
Etoposide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	1.19e-05	0.00023	CcSEcCtD
Etoposide—Somnolence—Epirubicin—peripheral nervous system neoplasm	1.19e-05	0.000229	CcSEcCtD
Etoposide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	1.18e-05	0.000227	CcSEcCtD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.17e-05	0.002	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.17e-05	0.00199	CbGpPWpGaD
Etoposide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	1.16e-05	0.000224	CcSEcCtD
Etoposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	1.16e-05	0.00198	CbGpPWpGaD
Etoposide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	1.16e-05	0.000223	CcSEcCtD
Etoposide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	1.16e-05	0.000222	CcSEcCtD
Etoposide—Fatigue—Epirubicin—peripheral nervous system neoplasm	1.15e-05	0.000222	CcSEcCtD
Etoposide—GSTT1—Metabolism—TH—peripheral nervous system neoplasm	1.15e-05	0.00196	CbGpPWpGaD
Etoposide—Pain—Epirubicin—peripheral nervous system neoplasm	1.15e-05	0.00022	CcSEcCtD
Etoposide—Constipation—Epirubicin—peripheral nervous system neoplasm	1.15e-05	0.00022	CcSEcCtD
Etoposide—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.14e-05	0.00194	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—AURKA—peripheral nervous system neoplasm	1.12e-05	0.00191	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.12e-05	0.0019	CbGpPWpGaD
Etoposide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	1.12e-05	0.0019	CbGpPWpGaD
Etoposide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	1.11e-05	0.000214	CcSEcCtD
Etoposide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	1.1e-05	0.000212	CcSEcCtD
Etoposide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	1.1e-05	0.000212	CcSEcCtD
Etoposide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	1.1e-05	0.000212	CcSEcCtD
Etoposide—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.1e-05	0.00187	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.1e-05	0.00187	CbGpPWpGaD
Etoposide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	1.1e-05	0.000211	CcSEcCtD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.09e-05	0.00186	CbGpPWpGaD
Etoposide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	1.08e-05	0.000207	CcSEcCtD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.08e-05	0.00183	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.08e-05	0.00183	CbGpPWpGaD
Etoposide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	1.07e-05	0.000206	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	1.07e-05	0.000205	CcSEcCtD
Etoposide—Urticaria—Epirubicin—peripheral nervous system neoplasm	1.06e-05	0.000205	CcSEcCtD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.06e-05	0.00181	CbGpPWpGaD
Etoposide—Constipation—Doxorubicin—peripheral nervous system neoplasm	1.06e-05	0.000204	CcSEcCtD
Etoposide—Pain—Doxorubicin—peripheral nervous system neoplasm	1.06e-05	0.000204	CcSEcCtD
Etoposide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	1.06e-05	0.000204	CcSEcCtD
Etoposide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	1.06e-05	0.000204	CcSEcCtD
Etoposide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	1.02e-05	0.000196	CcSEcCtD
Etoposide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	1.01e-05	0.000195	CcSEcCtD
Etoposide—TOP2A—Cell Cycle—CHEK2—peripheral nervous system neoplasm	1e-05	0.0017	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	9.97e-06	0.0017	CbGpPWpGaD
Etoposide—TOP2A—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	9.95e-06	0.00169	CbGpPWpGaD
Etoposide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.87e-06	0.00019	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.85e-06	0.000189	CcSEcCtD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	9.8e-06	0.00167	CbGpPWpGaD
Etoposide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.8e-06	0.000188	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.8e-06	0.000188	CcSEcCtD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	9.65e-06	0.00164	CbGpPWpGaD
Etoposide—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.61e-06	0.000185	CcSEcCtD
Etoposide—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.48e-06	0.000182	CcSEcCtD
Etoposide—GSTT1—Metabolism—GNAS—peripheral nervous system neoplasm	9.4e-06	0.0016	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.31e-06	0.00158	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.22e-06	0.00157	CbGpPWpGaD
Etoposide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	9.16e-06	0.000176	CcSEcCtD
Etoposide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	9.13e-06	0.000176	CcSEcCtD
Etoposide—UGT1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.1e-06	0.00155	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	8.98e-06	0.00153	CbGpPWpGaD
Etoposide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.89e-06	0.000171	CcSEcCtD
Etoposide—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.86e-06	0.00017	CcSEcCtD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	8.83e-06	0.0015	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.78e-06	0.00149	CbGpPWpGaD
Etoposide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.77e-06	0.000169	CcSEcCtD
Etoposide—PTGS2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.72e-06	0.00148	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	8.59e-06	0.00146	CbGpPWpGaD
Etoposide—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.52e-06	0.000164	CcSEcCtD
Etoposide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.48e-06	0.000163	CcSEcCtD
Etoposide—Rash—Epirubicin—peripheral nervous system neoplasm	8.45e-06	0.000162	CcSEcCtD
Etoposide—ABCC3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	8.44e-06	0.00144	CbGpPWpGaD
Etoposide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.44e-06	0.000162	CcSEcCtD
Etoposide—Headache—Epirubicin—peripheral nervous system neoplasm	8.39e-06	0.000161	CcSEcCtD
Etoposide—CYP2E1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.21e-06	0.0014	CbGpPWpGaD
Etoposide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	8.2e-06	0.000158	CcSEcCtD
Etoposide—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.19e-06	0.00139	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	8.13e-06	0.00138	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GNS—peripheral nervous system neoplasm	8.1e-06	0.00138	CbGpPWpGaD
Etoposide—Nausea—Epirubicin—peripheral nervous system neoplasm	7.96e-06	0.000153	CcSEcCtD
Etoposide—GSTP1—Metabolism—ENO2—peripheral nervous system neoplasm	7.94e-06	0.00135	CbGpPWpGaD
Etoposide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.88e-06	0.000152	CcSEcCtD
Etoposide—Rash—Doxorubicin—peripheral nervous system neoplasm	7.81e-06	0.00015	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.81e-06	0.00015	CcSEcCtD
Etoposide—Headache—Doxorubicin—peripheral nervous system neoplasm	7.76e-06	0.000149	CcSEcCtD
Etoposide—ABCC3—Metabolism—NME1—peripheral nervous system neoplasm	7.76e-06	0.00132	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.72e-06	0.00131	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	7.62e-06	0.0013	CbGpPWpGaD
Etoposide—ABCC1—Disease—GNS—peripheral nervous system neoplasm	7.58e-06	0.00129	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	7.54e-06	0.00128	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	7.48e-06	0.00127	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—COX2—peripheral nervous system neoplasm	7.47e-06	0.00127	CbGpPWpGaD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	7.45e-06	0.00127	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.42e-06	0.00126	CbGpPWpGaD
Etoposide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	7.37e-06	0.00125	CbGpPWpGaD
Etoposide—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.36e-06	0.000142	CcSEcCtD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.29e-06	0.00124	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	7.27e-06	0.00124	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	7.25e-06	0.00123	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.09e-06	0.00121	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	6.95e-06	0.00118	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—TP53—peripheral nervous system neoplasm	6.83e-06	0.00116	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.79e-06	0.00116	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	6.76e-06	0.00115	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—BCHE—peripheral nervous system neoplasm	6.71e-06	0.00114	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.69e-06	0.00114	CbGpPWpGaD
Etoposide—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.67e-06	0.00113	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	6.64e-06	0.00113	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.62e-06	0.00113	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	6.59e-06	0.00112	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GNS—peripheral nervous system neoplasm	6.58e-06	0.00112	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	6.44e-06	0.0011	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.4e-06	0.00109	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	6.36e-06	0.00108	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	6.34e-06	0.00108	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—TH—peripheral nervous system neoplasm	6.31e-06	0.00107	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—NME1—peripheral nervous system neoplasm	6.31e-06	0.00107	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.19e-06	0.00105	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	6.19e-06	0.00105	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.18e-06	0.00105	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.17e-06	0.00105	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	6.08e-06	0.00103	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—COX2—peripheral nervous system neoplasm	6.07e-06	0.00103	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.95e-06	0.00101	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	5.94e-06	0.00101	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.89e-06	0.001	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	5.85e-06	0.000996	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.82e-06	0.00099	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	5.58e-06	0.00095	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.54e-06	0.000943	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.53e-06	0.000941	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.39e-06	0.000916	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	5.38e-06	0.000916	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	5.36e-06	0.000912	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	5.35e-06	0.00091	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.32e-06	0.000905	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	5.31e-06	0.000902	CbGpPWpGaD
Etoposide—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	5.3e-06	0.000901	CbGpPWpGaD
Etoposide—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.28e-06	0.000899	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.23e-06	0.000889	CbGpPWpGaD
Etoposide—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.22e-06	0.000888	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	5.15e-06	0.000876	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—GNAS—peripheral nervous system neoplasm	5.15e-06	0.000876	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	5.15e-06	0.000875	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	5.14e-06	0.000875	CbGpPWpGaD
Etoposide—PTGS2—Disease—GNS—peripheral nervous system neoplasm	5.08e-06	0.000865	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.05e-06	0.000859	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	4.95e-06	0.000842	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	4.94e-06	0.00084	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.93e-06	0.000839	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	4.91e-06	0.000834	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.89e-06	0.000832	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	4.86e-06	0.000827	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	4.81e-06	0.000819	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.79e-06	0.000815	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.68e-06	0.000797	CbGpPWpGaD
Etoposide—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.6e-06	0.000782	CbGpPWpGaD
Etoposide—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	4.59e-06	0.000781	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	4.48e-06	0.000763	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	4.26e-06	0.000724	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	4.23e-06	0.000719	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.17e-06	0.00071	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	4.14e-06	0.000705	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	4.08e-06	0.000694	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	4.03e-06	0.000685	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	4.01e-06	0.000682	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	4e-06	0.00068	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ENO2—peripheral nervous system neoplasm	3.99e-06	0.000678	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.98e-06	0.000677	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.95e-06	0.000673	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	3.93e-06	0.000668	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	3.9e-06	0.000663	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	3.84e-06	0.000654	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	3.84e-06	0.000654	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	3.83e-06	0.000652	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.81e-06	0.000648	CbGpPWpGaD
Etoposide—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	3.7e-06	0.000629	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	3.7e-06	0.000629	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	3.69e-06	0.000628	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	3.65e-06	0.000621	CbGpPWpGaD
Etoposide—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	3.56e-06	0.000605	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	3.5e-06	0.000596	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	3.5e-06	0.000596	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	3.46e-06	0.000589	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	3.38e-06	0.000575	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—BCHE—peripheral nervous system neoplasm	3.37e-06	0.000573	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.33e-06	0.000567	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	3.32e-06	0.000565	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—MYC—peripheral nervous system neoplasm	3.26e-06	0.000555	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	3.25e-06	0.000553	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	3.25e-06	0.000552	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.21e-06	0.000547	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	3.2e-06	0.000544	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	3.18e-06	0.000541	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.18e-06	0.000541	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—TH—peripheral nervous system neoplasm	3.17e-06	0.000539	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.15e-06	0.000535	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	3.12e-06	0.000531	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.1e-06	0.000527	CbGpPWpGaD
Etoposide—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	3.08e-06	0.000524	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	3.05e-06	0.000519	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	3.02e-06	0.000513	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.89e-06	0.000492	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.88e-06	0.000489	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	2.86e-06	0.000486	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	2.79e-06	0.000474	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.77e-06	0.000471	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	2.75e-06	0.000467	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.73e-06	0.000464	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	2.69e-06	0.000457	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—peripheral nervous system neoplasm	2.68e-06	0.000456	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.62e-06	0.000446	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—GNAS—peripheral nervous system neoplasm	2.59e-06	0.00044	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	2.58e-06	0.000439	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	2.58e-06	0.000439	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.57e-06	0.000437	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.54e-06	0.000431	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—AKT1—peripheral nervous system neoplasm	2.54e-06	0.000431	CbGpPWpGaD
Etoposide—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.53e-06	0.000431	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	2.49e-06	0.000424	CbGpPWpGaD
Etoposide—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	2.48e-06	0.000422	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.48e-06	0.000422	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.45e-06	0.000416	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	2.43e-06	0.000413	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.43e-06	0.000413	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	2.42e-06	0.000412	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	2.41e-06	0.00041	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	2.31e-06	0.000393	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	2.22e-06	0.000378	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	2.19e-06	0.000373	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	2.18e-06	0.000371	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.15e-06	0.000366	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	2.11e-06	0.000358	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	2.1e-06	0.000357	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.08e-06	0.000354	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	2.07e-06	0.000352	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.07e-06	0.000352	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	2.05e-06	0.000349	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	2.05e-06	0.000349	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	2.05e-06	0.000348	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.04e-06	0.000347	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.96e-06	0.000333	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.95e-06	0.000332	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	1.93e-06	0.000328	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	1.93e-06	0.000327	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.86e-06	0.000316	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.83e-06	0.000311	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.78e-06	0.000303	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	1.77e-06	0.000302	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.72e-06	0.000293	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.72e-06	0.000292	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.69e-06	0.000288	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	1.67e-06	0.000285	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	1.67e-06	0.000284	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.64e-06	0.000279	CbGpPWpGaD
Etoposide—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	1.63e-06	0.000278	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	1.57e-06	0.000268	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	1.57e-06	0.000267	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.55e-06	0.000263	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.55e-06	0.000263	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	1.54e-06	0.000262	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.47e-06	0.000251	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.46e-06	0.000248	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.45e-06	0.000247	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—peripheral nervous system neoplasm	1.39e-06	0.000236	CbGpPWpGaD
Etoposide—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	1.39e-06	0.000236	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	1.36e-06	0.000232	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	1.34e-06	0.000227	CbGpPWpGaD
Etoposide—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	1.24e-06	0.000212	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.23e-06	0.00021	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	1.19e-06	0.000202	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.18e-06	0.0002	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	1.16e-06	0.000197	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—peripheral nervous system neoplasm	1.16e-06	0.000197	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.13e-06	0.000192	CbGpPWpGaD
Etoposide—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	1.1e-06	0.000187	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	9.52e-07	0.000162	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	9.47e-07	0.000161	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	9.29e-07	0.000158	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	9.1e-07	0.000155	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.08e-07	0.000154	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	8.95e-07	0.000152	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	8.59e-07	0.000146	CbGpPWpGaD
Etoposide—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	8.35e-07	0.000142	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	8.03e-07	0.000137	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—peripheral nervous system neoplasm	7.78e-07	0.000132	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	7.31e-07	0.000124	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	7.17e-07	0.000122	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—peripheral nervous system neoplasm	6.98e-07	0.000119	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	6.73e-07	0.000114	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	6.11e-07	0.000104	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	5.92e-07	0.000101	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	5.69e-07	9.68e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	5.39e-07	9.17e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	4.52e-07	7.68e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	4.25e-07	7.23e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	4.24e-07	7.22e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	3.67e-07	6.25e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	3.2e-07	5.44e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.56e-07	4.35e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.97e-07	3.35e-05	CbGpPWpGaD
